
CAS 1025821-33-3
:Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
6 produits concernés.
GSK-626616
CAS :GSK-626616: strong, oral DYRK3 inhibitor (IC50: 0.7 nM), affects DYRK family, may treat anemia.Formule :C18H10Cl2N4OSDegré de pureté :98.27%Couleur et forme :SolidMasse moléculaire :401.27(5Z)-2-[(2,6-Dichlorophenyl)amino]-5-(6-quinoxalinylmethylene)-4(5H)-thiazolone
CAS :Formule :C18H10Cl2N4OSDegré de pureté :98%Couleur et forme :SolidMasse moléculaire :401.2692GSK 626616
CAS :<p>Potent inhibitor of dual specificity tyrosine-phosphorylation-regulated kinase 3 (DYRK3) with IC50 value of 0.7 nM. Elevates hemoglobin and platelet levels in anemic mice.</p>Formule :C18H10Cl2N4OSDegré de pureté :Min. 98 Area-%Couleur et forme :PowderMasse moléculaire :401.27 g/molGSK 626616 - Bio-X ™
CAS :This product is part of our Bio-X ™ Range. These products are aimed at life science researchers who need high quality ready-to-use products for assay development, screening or other R&D work. With a solubility datasheet and convenient vials, all of our Bio-X ™ products are in stock across our global warehouses for rapid delivery and ease of use.Formule :C18H10Cl2N4OSDegré de pureté :Min. 95%Couleur et forme :PowderMasse moléculaire :401.27 g/molGSK-626616
CAS :Produit contrôlé<p>Applications GSK-626616 is a potent and selective DYRK inhibitor (IC50 = 0.7 nM for DYRK3, similar potency for DYRK1 and 2). Exhibits ~20-fold selectivity over casein kinase 2 and negligible activity against a panel of 451 kinases screened. Enhances number of CFU-E stimulated by Epo from human marrow. Increases hemoglobin levels in anemic mice. Orally bioavailable.<br>References Wippich, Frank., et al.: Cell., 152, 791(2013); Corona, John A., et al.: Org. Process Res. Dev., 14, 712 (2010)<br></p>Formule :C18H10Cl2N4OSCouleur et forme :YellowMasse moléculaire :401.27




